NASDAQ:XRAY - DENTSPLY SIRONA Stock Price, Price Target & More

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

DENTSPLY SIRONA declared a quarterly dividend on Tuesday, June 26th. Stockholders of record on Friday, September 28th will be given a dividend of $0.0875 per share on Friday, October 12th. This represents a $0.35 annualized dividend and a dividend yield of 0.78%. The ex-dividend date is Thursday, September 27th. View DENTSPLY SIRONA's Dividend History.

DENTSPLY SIRONA Inc (NASDAQ:XRAY) posted its quarterly earnings data on Sunday, May, 6th. The medical instruments supplier reported $0.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.42 by $0.03. The medical instruments supplier had revenue of $956.10 million for the quarter, compared to analysts' expectations of $942.20 million. DENTSPLY SIRONA had a positive return on equity of 8.63% and a negative net margin of 38.32%. The firm's quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.49 EPS. View DENTSPLY SIRONA's Earnings History.

DENTSPLY SIRONA is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for DENTSPLY SIRONA.

DENTSPLY SIRONA updated its FY18 earnings guidance on Monday, May, 7th. The company provided EPS guidance of $2.55-2.65 for the period, compared to the Thomson Reuters consensus estimate of $2.70.

14 brokers have issued twelve-month price targets for DENTSPLY SIRONA's shares. Their predictions range from $52.00 to $75.00. On average, they anticipate DENTSPLY SIRONA's share price to reach $61.4167 in the next year. This suggests a possible upside of 36.4% from the stock's current price. View Analyst Ratings for DENTSPLY SIRONA.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last year. There are currently 5 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to DENTSPLY SIRONA include Straumann (SAUHF), Sartorius (SARTF), Nobel Biocare (NBHGF), Biomerica (BMRA), BIOLASE (BIOL) and Remedent (REMI).

News articles about XRAY stock have been trending somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. DENTSPLY SIRONA earned a news impact score of 0.20 on Accern's scale. They also gave media stories about the medical instruments supplier an impact score of 47.78 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

DENTSPLY SIRONA's stock is owned by a variety of of retail and institutional investors. Top institutional investors include GENERATION INVESTMENT MANAGEMENT LLP (5.20%), Bank of Montreal Can (0.10%), Channing Capital Management LLC (0.10%), Stonebridge Capital Management Inc. (0.06%), First National Bank of Omaha (0.05%) and Retirement Systems of Alabama (0.05%). Company insiders that own DENTSPLY SIRONA stock include Arthur D Kowaloff, Bret W Wise, Christopher T Clark, Donald M Jr Casey, Eric Brandt, Francis J Lunger, James G Mosch, Mark Thierer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman, Nicholas W Alexos, Rainer Berthan and Ulrich Michel. View Institutional Ownership Trends for DENTSPLY SIRONA.

XRAY stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Clinton Group Inc., Channing Capital Management LLC, Hartford Investment Management Co., Nisa Investment Advisors LLC, Hills Bank & Trust Co., Fjarde AP Fonden Fourth Swedish National Pension Fund and Bath Savings Trust Co. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Eric Brandt, Francis J Lunger, Michael C Alfano and Michael J Coleman. View Insider Buying and Selling for DENTSPLY SIRONA.

XRAY stock was purchased by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Stonebridge Capital Management Inc., FormulaFolio Investments LLC, Bank of Montreal Can, Cornerstone Wealth Management LLC, Rowland & Co. Investment Counsel ADV, IFM Investors Pty Ltd and DnB Asset Management AS. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Donald M Jr Casey, Mark Thierer and Nicholas W Alexos. View Insider Buying and Selling for DENTSPLY SIRONA.

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of XRAY stock can currently be purchased for approximately $45.03.

DENTSPLY SIRONA has a market capitalization of $10.31 billion and generates $3.99 billion in revenue each year. The medical instruments supplier earns $-1,550,000,000.00 in net income (profit) each year or $2.66 on an earnings per share basis. DENTSPLY SIRONA employs 16,100 workers across the globe.

DENTSPLY SIRONA's mailing address is 221 WEST PHILADELPHIA STREET, YORK PA, 17401. The medical instruments supplier can be reached via phone at 717-845-7511 or via email at [email protected]